Highlights

Including Capsule Summaries on-demand audio a comprehensive downloadable slideset and ClinicalThought commentaries this program provides expert insight on the hot topics from the HIV fall conferences.

Share

Program Content

Activities

  • Slides on Fall 2019 HIV Data
    Clinical Impact of New HIV Data From Fall 2019 Conferences
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 02, 2019

  • PrEP at IDWeek 2019
    How New Data From IDWeek 2019 Estimate the Impact of PrEP Across Major US Cities
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

  • Data on Women at EACS 2019
    Implications of New Data From EACS 2019 for Women With HIV
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 29, 2020

Activities

Weight Change With DOR
Low Weight Gain Over 96 Wks in Treatment-Naive Patients Initiating ART With Doravirine
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2019

BIC/FTC/TAF in Women
BIC/FTC/TAF Safe and Efficacious in Women and Girls Across 5 Phase II/III Clinical Trials
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2019

TANGO Subgroup Analysis
TANGO: Switch to DTG/3TC Maintains Virologic Suppression at Wk 48 Across Patient Demographics and Baseline Third Agent Classes
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2019

DISCOVER
DISCOVER: Renal Parameters and BMD Improved With FTC/TAF vs FTC/TDF for HIV PrEP at Wk 48
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 19, 2019

PrEP in US Metropolitan Areas
Increased PrEP Uptake in US Metropolitan Statistical Areas During 2012-2017 Associated With Significant Reduction in New HIV Diagnoses Rate
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2019

LATTE
LATTE: Durable Viral Suppression With Oral Cabotegravir + Rilpivirine Maintenance Therapy Through Wk 312
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2019

GEMINI
GEMINI-1 and -2: Subgroup Analyses Consistent With Overall Safety and Efficacy Findings for DTG + 3TC in ART-Naive Adults at Wk 96
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 31, 2019

RAL Safety in Pregnancy
No Increase in Adverse Birth Outcomes Following Exposure to Raltegravir in Pregnancy
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2019

DIAMOND
DIAMOND: High Virologic Suppression Rates Achieved Following Rapid Initiation of DRV/COBI/FTC/TAF Regardless of Baseline HIV-1 RNA Level or CD4+ Cell Count
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 29, 2019

PrEP BMD Study
Longitudinal Cohort Study Demonstrates Notable Rate of > 3% BMD Loss Over 2 Yrs Among MSM Receiving TDF-Based PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 19, 2019

Provided by

ProCE Banner

Supporters

Gilead

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare